Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules and peptide-like structures. Its protected amine group and morpholine ring make it valuable in medicinal chemistry for constructing complex molecules with enhanced solubility and stability. Commonly employed in solid-phase and solution-phase peptide synthesis due to the Cbz protecting group, which allows selective deprotection under mild conditions. Also utilized in the preparation of enzyme inhibitors and receptor ligands where the morpholine scaffold contributes to target binding and pharmacokinetic properties.